Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandibular Disorders

ClinicalTrials.gov ID: NCT05262517

Public ClinicalTrials.gov record NCT05262517. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 1:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Safety and Efficacy Trial of BHV-3000 (Rimegepant) Orally Disintegrating Tablet (ODT) for the Acute Treatment of Temporomandibular Disorders (TMD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the efficacy and safety of rimegepant versus placebo in the acute treatment of Temporomandibular Disorders (TMD), which are medical conditions involving the temporomandibular joint (the joint connecting the jawbone to the skull) and surrounding muscles and tissues.

Study identification

NCT ID
NCT05262517
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
126 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 5, 2022 (Actual)
Primary completion
May 18, 2023 (Actual)
Completion
May 18, 2023 (Actual)
Last update posted
May 16, 2024

2022 – 2023

United States locations

U.S. sites
32
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
Bruce Nelson, DDS Phoenix Arizona 85020 —
Arizona Research Center Phoenix Arizona 85053 —
The Medici Medical Research, LLC Hollywood Florida 33021 —
The Medici Medical Research Hollywood Florida 33021 —
SouthCoast Research Center, Inc Miami Florida 33136 —
SouthCoast Research Center Miami Florida 33136 —
Oceane7 Medical & Research Center, Inc. Miami Florida 33144 —
Florida Craniofacial Institute Tampa Florida 33607 —
Forcare Clinical Research Tampa Florida 33613 —
Campus Health, Indiana University-Purdue University Indianapolis Indianapolis Indiana 46202 —
IDS-IU Simon Cancer Center (IUSCC) Indianapolis Indiana 46202 —
Indiana University School of Dentistry Indianapolis Indiana 46202 —
University of Kentucky, College of Dentistry Lexington Kentucky 40536 —
TMD, Orofacial Pain and Dental Sleep Medicine Clinic, School of Dentistry, University of Minnesota Minneapolis Minnesota 55455 —
University of Minnesota Minneapolis Minnesota 55455 —
Clinvest Research, LLC Springfield Missouri 65807 —
Clinvest Research Springfield Missouri 65810 —
North Suffolk Neurology Commack New York 11725 —
University of Rochester Rochester New York 14618 —
Duke University Raleigh North Carolina 27617 —
META Medical Research Institute,LLC. Dayton Ohio 45432 —
Meta Medical Research Dayton Ohio 45432 —
Kulkarni Orthodonties Springboro Ohio 45066 —
Perelman Center for Advanced Medicine Philadelphia Pennsylvania 19104 —
University of Pittsburgh Pittsburgh Pennsylvania 15201 —
Red Star Research, LLC Lake Jackson Texas 77566 —
Red Star Research Lake Jackson Texas 77566 —
FMC Science Lampasas Texas 76550 —
JBR Clinical Research Salt Lake City Utah 84107 —
JBR Salt Lake City Utah 84107 —
Northwest Clinical Research Center Bellevue Washington 98007 —
Snoring and Sleep Apnea Center (DC/TMD Exam - Dr. Christian) Seattle Washington 98121 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05262517, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 16, 2024 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05262517 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →